The 2011 Omnibus Solicitation is an investigator-initiated grant funding opportunity that enables small businesses to apply for funding across a wide range of cancer related topic areas. U.S. small businesses with the research capabilities and technological expertise described in the Omnibus Solicitation are encouraged to submit investigator-initiated SBIR & STTR grant applications for the identified topics. The next deadline for receipt of NCI SBIR & STTR 2011 Omnibus Solicitation proposals is August 5, 2011. For more general information about this opportunity, please visit http://sbir.cancer.gov/funding/omnibus/.
Additionally, the NCI SBIR & STTR Program has funding opportunities available in a wide range of cancer related topic areas. Some of these grants have upcoming deadlines in July and August 2011. For a complete listing of funding opportunities from the NCI SBIR & STTR Programs, please visit http://sbir.cancer.gov/funding/find_funding.asp.
The NCI SBIR & STTR Programs are structured in three phases:
· Phase I support is normally $150,000 provided over a period of 6 months for SBIR and $100,000 over a period of 1 year for STTR.
· Phase II awards are typically $1 million over 2 years for SBIR and $750,000 over 2 years for STTR. Only Phase I awardees are eligible for a Phase II award.
· Phase II Bridge Awards are provided to previously funded NIH SBIR Phase II awardees to address the funding gap between the end of the Phase II award and the commercialization stage. A total of $3 million over 3 years may be requested from the NCI.
For resources and tips for applying, and for examples of SBIR grant applications, please visit http://sbir.cancer.gov/resource/apply/.